Close Menu

The Wall Street Journal has an article focusing on Andrew von Eschenbach, commissioner of the US Food and Drug Administration. Critics have charged that the FDA can't manage regulations of everything it's supposed to be regulating, and now von Eschenbach responds that "the agency needs more money than the Bush administration has proposed, and it requires a revamped organization to better oversee drug safety and other issues," according to the article.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.